Volume : 13, Issue : 01, January – 2026

Title:

NANOTECHNOLOGY
THE FUTURE OF TARGETED DRUG DELIVERY AND CONTROLLED DRUG DELIVERY IN PHARMACEUTICS

Authors :

Mrs. Ayesha Siddiqua Gazi, Adeeba Mahveen, Sania Naaz, Saboor Arshi

Abstract :

Nanotechnology is a rapidly advancing interdisciplinary domain that encompasses the design, synthesis, characterization, and application of materials and devices at the nanoscale, typically within the range of 1–100 nm. This field has significantly transformed numerous scientific and industrial sectors, including medicine, electronics, energy, and environmental sciences. In the pharmaceutical sciences, nanotechnology has become a cornerstone for developing innovative drug delivery systems such as nanosuspensions, liposomes, polymeric nanoparticles, metallic nanoparticles, and nanogels. These nano-based platforms enhance drug solubility, improve bioavailability, and enable precise and targeted delivery.
The present review provides an in-depth understanding of the fundamental concepts of nanotechnology, various classes of nanoparticles, and their broad applications in pharmaceutics. It further outlines recent progress in nanotechnology-enabled drug delivery systems, with an emphasis on targeting mechanisms and their therapeutic applications in cancer, neurological disorders, and infectious diseases. Additionally, the review discusses existing challenges, regulatory considerations, and future directions that may influence the successful translation of nanomedicine from experimental research to clinical practice. Overall, nanotechnology continues to hold immense promise in redefining the future of pharmaceutical science by supporting the development of more effective, precise, and personalized therapeutic strategies.
Keywords: Nanotechnology, Micelle, Liposomes, Dendrimers, Carbon nanotubes, Quantum dots, Top down, bottom up, Characterization, Nanomedicine, Anticancer, Diabetes, Textiles, Energy, Environment, Controlled drug delivery, Targeted drug delivery.

Cite This Article:

Please cite this article in press Ayesha Siddiqua Gazi et al., Nanotechnology-The Future Of Targeted Drug Delivery And Controlled Drug Delivery In Pharmaceutics, Indo Am. J. P. Sci, 2026; 13(01).

REFERENCES:

1. Mansoori GA. Principles of Nanotechnology: Molecular-Based Study of Condensed Matter in Small Systems. Singapore: World Scientific; 2011.
2. Binns C. Introduction to Nanoscience and Nanotechnology. Hoboken (NJ): Wiley; 2021.
3. Roco MC. The emergence and policy implications of converging new technologies. J Nanopart Res. 2005;7(2–3):129–43.
4. Mitragotri S, et al. Engineering of nanoparticles for targeted drug delivery. Nat Rev Drug Discov. 2022;21(6):424–48.
5. Torchilin V. Multifunctional nanocarriers. Nat Rev Drug Discov. 2014;13:813–27.
6. Duncan R, Gaspar R. Nanomedicine—lessons learned. Adv Drug Deliv Rev. 2010;62:188–91.
7. Davis ME, et al. Nanoparticle therapeutics: an emerging treatment modality. Nanomedicine. 2007;2(6):789–803.
8. Svenson S. Dendrimers as versatile platform in drug delivery. Adv Drug Deliv Rev. 2005;57:2106–29.
9. Akbarzadeh A, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8:102.
10. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001;73:137–72.
11. Peer D, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751–60.
12. Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153:198–205.
13. Shi J, et al. Nanotechnology in drug delivery and tissue engineering. J Exp Clin Cancer Res. 2020;39:1–23.
14. Müller H, et al. Top-down and bottom-up engineered nanoparticles for drug delivery. Small. 2010;6(20):2336–45.
15. Müller RH, Peters K. Nanosuspensions for poorly soluble drugs. Adv Drug Deliv Rev. 2001;47:3–19.
16. Barocas MRJ, et al. Supercritical fluid technology in pharmaceutical science. J Supercrit Fluids. 2018;134:40–52.
17. Alexis F, et al. Nanotechnology and future drug delivery. Curr Opin Pharmacol. 2008;8:339–45.
18. Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3:16–20.
19. Islam MS, Rahman M. Nanosuspension technology: recent progress in drug delivery. APS PharmSciTech. 2020;21:299–312.
20. Zhu X, et al. Nanotechnology in the diagnosis and treatment of coronary artery disease. Adv Drug Deliv Rev. 2022;182:114097.
21. Li M, et al. Nanomaterial-based biosensors for cardiovascular biomarker detection. Biosens Bioelectron. 2021;171:112687.
22. Wong BS, et al. Nanoparticle-enhanced imaging for atherosclerosis. Nat Rev Cardiol. 2020;17:593–604.
23. Zhang J, et al. Biomimetic and natural nanoparticles for targeted cardiovascular therapy. ACS Nano. 2021;15(2):3119–37.
24. Chong JJ, et al. Theranostic nanoplatforms for coronary artery disease. J Control Release. 2023;355:90–108.
25. Wilson R, Turner APF. Glucose oxidase: an ideal enzyme. Biosens Bioelectron. 1992;7(3):165–85.
26. Zhang R, Xu W. Nanotechnology in glucose monitoring: a review. Anal Chim Acta. 2014;806:1–12.
27. Pickup JC, Hussain F. Nanomedicine and its potential in diabetes research and practice. Diabetes Metab Res Rev. 2015;31(6):604–10.
28. Veiseh O, et al. Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov. 2015;14:45–57.
29. Gu Z, et al. Glucose-responsive micro/nanosystems for closed-loop insulin delivery. ACS Nano. 2013;7(8):6758–66.
30. Montazer M, Harifi T. Nanotechnology in Textiles: Advances and Developments. Cambridge: Woodhead Publishing; 2018.
31. Shah T, Adivarekar RV, Desai AN. Application of nanotechnology in textiles. J Text Eng Fashion Technol. 2015;1(1):1–7.
32. Wang X, Lin T. Nanotechnology for the textile industry: a review. J Text Inst. 2008;99(2):1–7.
33. De Azeredo HMC. Nanocomposites for food packaging applications. Food Res Int. 2009;42(9):1240–53.
34. Holme I. Innovative textile treatments using nanotechnology. Coloration Technol. 2007;123(2):59–73.
35. Jain P, Huang X, El-Sayed I, El-Sayed M. Surface plasmon resonance-enhanced properties of noble metal nanoparticles. Chem Phys Lett. 2010;487(4–6):153–64.
36. De M, Ghosh PS, Rotello VM. Applications of nanoparticles in biology. Adv Mater. 2008;20(22):4225–41.
37. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J. 2005;19(3):311–30.
38. Novoselov KS, et al. A roadmap for graphene. Nature. 2012;490(7419):192–200.
39. Iijima S. Helical microtubules of graphitic carbon. Nature. 1991;354:56–8.
40. (Duplicate of reference 39; foundational CNT paper, already included).
41. Varadan RS, Chen L, Xie J. Nanomedicine: Design and Applications of Magnetic Nanomaterials, Nanosensors and Nanosystems. Hoboken (NJ): Wiley; 2008.
42. Zhang L, Gu F, Chan J. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83(5):761–9.
43. Bansal S, Bansal M, Kumria R. Nanocrystals: current strategies and trends. Int J Res Pharm Biomed Sci. 2012;3(1):406–19.
44. Rasanta D. Nanotechnology for the delivery of poorly water-soluble drugs. Glob J Pharm Res. 2012;1(3):225–50.
45. Patel M. Nanosuspension: a novel approach for drug delivery system. JPSBR. 2011;1:1–10.
46. Yadav GV. Nanosuspension: a promising drug delivery system. Pharmacophore. 2012;3(5):217–43.
47. Malik A, Chaudhary S, Garg G, Tomar A. Dendrimers: a tool for drug delivery. Adv Biol Res. 2012;6(4):165–9.
48. Heera P, Shanmugam S. Nanoparticle characterization and application: an overview. Int J Curr Microbiol Appl Sci. 2015;4(8):379–86.
49. Shahidulla SM, Miskan R, Sultana S. Nanosuspensions in pharmaceutical sciences: a comprehensive review. Int J Health Sci Res. 2023;13(7):332–42. doi:10.52403/ijhsr.20230745.
50. Mengesha Y. Nanotechnology-enhanced controlled-release systems in topical therapeutics. Precision Nanomedicine. 2024;7(1):1365–85.
51. Di Stefano A. Nanotechnology in targeted drug delivery. Int J Mol Sci. 2023;24(9):8194. doi:10.3390/ijms24098194.
52. Patra JK, et al. Recent developments and future prospects. J Nanobiotechnology. 2018;16:71. doi:10.1186/s12951-018-0392-8.
53. Yvon BK. The impact of nanoscience and nanotechnology on controlled drug delivery. Nanomedicine. 2014;9(4):401. doi:10.2217/nnm.14.4.
54. Omietimi HB, et al. An overview of nanotechnology and its application. E3S Web Conf. 2023;391:01079. doi:10.1051/e3sconf/202339101079.
55. Rangasamy M. Nano technology: a review. J Appl Pharm Sci. 2011;1(2):8–16.
56. Alhlimidi SRH, Thillah SHK, Al-Musawi KA. Principles of nanotechnology (article review). Int J Multidiscip Res Dev. 2023;10(7):74–6.
57. Gavrilescu C-M, et al. The advantages and disadvantages of nanotechnology. Rom J Oral Rehabil. 2018;10(2):153–7.
58. Rónavári A, et al. Study of parameters influencing the co-grinding process for the production of meloxicam nanoparticles. Powder Technol. In press.
59. Marinelli L, et al. Hydrophilic peptide loaded PEG–PLGA nanoparticles. Pharmaceutics. 2022;14(9):1821. doi:10.3390/pharmaceutics14091821.
60. Cacciatore BKR, et al. Multiple lipid nanoparticles as antimicrobial drug delivery systems. J Drug Deliv Sci Technol. 2022;67:102887. doi:10.1016/j.jddst.2021.102887.